Industry News
Qld company raises millions for drug research
A Queensland biotechnology company has raised AU$11.9 m to fund the development of new types of therapeutic drugs.
[ + ]Australian invention commercialised
A Royal North Shore Hospital discovery has been commercialised by US company Beckman Coulter, manufacturer of biomedical testing equipment, through its DSL subsidiary.
[ + ]Fishy links: Killer B cells and evolution
Researchers from the University of Pennsylvania School of Veterinary Medicine have discovered a unique evolutionary link between the immune systems of fish and mammals in the form of a primitive version of B cells, white blood cells of the immune system. [ + ]
How Chemeq hopes to save its bacon
The last couple of years have been rather disastrous for West Australian biotech Chemeq, manufacturer of polymer microbials for pigs and poultry. However, a new management team has come up with a plan to turn its fortunes around, as Kate McDonald reports. [ + ]
Research excellence showcased
Eight up-and-coming University of Queensland researchers have received awards at the 2006 UQ Foundation Research Excellence Awards held at Brisbane Customs House.
[ + ]Brainy students create world first
A 3D brain model is at the centre of a project created by a group of postgraduate students based at Melbourne’s Howard Florey Institute.
[ + ]R-nomics and the central dogma of biology
Professor John Mattick is challenging the orthodoxy that selfish DNA is the cornerstone of the genome. Regulatory RNA is where it's all happening, as Graeme O'Neill reports. [ + ]
Breathtaking results in Alzheimer's drug trial
When the news of remarkable results in a pre-clinical trial of a potential drug for Alzheimer's disease was released in July, the headlines screamed and the share price for Prana Biotechnology went through the roof. Graeme O'Neill probes the details. [ + ]
New chair gives the goods on NHMRC
Federal Health Minister Tony Abbott recently announced the 19 members of the National Health and Medical Research Council (NHMRC) for the next three years, presenting the head of one of Australia's largest medical research institutes, Professor Michael Good, with an unexpected but very welcome new challenge. Fiona Wylie reports. [ + ]
Here we go again: what next for stem cells?
With developments in the embryonic stem cell debate changing as quickly as Melbourne's weather, Kate McDonald asked two of Australia's leading researchers - Stephen Livesey and Bernie Tuch - what would happen should the recommendations of the Lockhart Review be implemented. [ + ]
Wnt and the tissue-regeneration symphony
Is it possible to re-awaken dormant pathways in humans to regenerate tissue? Graeme O'Neill talks to Professor Randall Moon about the Wnt family of cell-signalling proteins. [ + ]
Array CGH enters the realm of clinical diagnostics
The power of array CGH to detect chromosomal losses and gains across the genome is sparking moves into clinical diagnostics, as Kate McDonald reports. [ + ]
Out of Africa: the future of GM crops
Nowhere is the potential of agricultural biotechnology and GM crops more obvious than in Africa, as Graeme O'Neill reports. [ + ]
The green gene revolution in India
GM giant Monsanto may be the bete noire of the anti-GM movement, but its scientists, particularly in India, are moving ahead with the Green Revolution, as Graeme O'Neill reports. [ + ]
TraitMill: serial cereal phenotyping
An enormous, high-security greenhouse in the countryside 20km north of Ghent in Belgium hints at the high-technology future of crop breeding in the 21st century. Graeme O'Neill reports. [ + ]
